US2009306776A1PendingUtilityA1
Methods and procedures for ligament repair
Est. expiryJan 25, 2026(expired)· nominal 20-yr term from priority
Inventors:Martha M. Murray
A61L 27/56A61B 2017/00004A61B 2017/0458A61L 27/52A61L 27/22A61L 27/24A61B 2017/0414A61B 2017/044A61L 2430/10A61F 2002/0888A61L 17/12A61B 17/0401A61B 17/1146A61B 17/0469A61B 2017/00893A61F 2/0811
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods and devices for the repair of a ruptured ligament using a scaffold device are provided. Aspects of the invention, may include a scaffold attached by a suture to an anchor. In aspects of the invention, the anchor may be secured to a bone near or at the repair site.
Claims
exact text as granted — not AI-modified1 .- 86 . (canceled)
87 . A construct for repair or augmentation of a tissue exposed to synovial fluid comprising a compressible porous support scaffold configured for repair or augmentation of the tissue, wherein the scaffold allows cell ingrowth.
88 . The construct of claim 87 , wherein the tissue is a ligament, tendon, meniscus, cartilage, labrum or muscle.
89 . The construct of claim 88 , wherein the ligament is an ACL.
90 . The construct of claim 87 , wherein the scaffold is expandable.
91 . The construct of claim 87 , further comprising a suture.
92 . The construct of claim 91 , wherein the suture is bioabsorbable.
93 . The construct of claim 87 , further comprising an anchor.
94 . The construct of claim 93 , wherein the anchor is selected from the group consisting of a screw, a barb, a helical anchor, a staple, a clip, a snap, and a rivet.
95 . The construct of claim 87 , further comprising a bone insertion device.
96 . The construct of claim 87 , wherein the scaffold comprises a therapeutic agent.
97 . The construct of claim 5 , wherein the therapeutic agent is selected from the group consisting of hormones, cytokines, growth factors, clotting factors, anti-protease proteins, angiogenic proteins, antiangiogenic proteins, bone morphogenic proteins, osteoinductive factor, fibronectin, endothelial cell growth factor, cementum attachment extracts, ketanserin, human growth hormone, animal growth hormones, epidermal growth factor, interleukin-1, human alpha thrombin, transforming growth factor, insulin-like growth factor, platelet derived growth factors, fibroblast growth factors, and periodontal ligament chemotactic factors.
98 . The construct of claim 87 , wherein the scaffold comprises a clotting factor.
99 . The construct of claim 87 , wherein the scaffold comprises platelets or platelet rich plasma.
100 . The construct of claim 87 , wherein the scaffold comprises collagen.
101 . The construct of claim 87 , wherein the scaffold is a sponge.
102 . The construct of claim 87 , wherein the scaffold is tubular, semi-tubular, or cylindrical.
103 . The construct of claim 87 , wherein the scaffold is an amorphous shape that conforms to the shape of a repair space.
104 . The construct of claim 87 , comprising the scaffold, at least one bone insertion device and at least one suture.
105 . The construct of claim 104 , comprising a platelet and a clotting factor in the scaffold.
106 . The construct of claim 87 , wherein the construct further comprises xenograft tissue, allograft tissue, or autograft tissue.
107 . A kit comprising the construct of claim 87 , and a scaffold, suture, and a bone insertion device.
108 . A kit comprising the construct of claim 87 , a scaffold and platelets or means for obtaining platelets from a patient.
109 . The kit of claim 107 or 108 , further comprising a therapeutic agent.
110 . The kit of claim 109 , wherein the therapeutic agent is a clotting factor.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.